Results 211 to 220 of about 72,150 (302)

RETRACTED: Batool et al. Development and Evaluation of Cellulose Derivative and Pectin Based Swellable pH Responsive Hydrogel Network for Controlled Delivery of Cytarabine. <i>Gels</i> 2023, <i>9</i>, 60. [PDF]

Gels
Batool N, Sarfraz RM, Mahmood A, Rehman U, Zaman M, Akbar S, Almasri DM, Gad HA.   +7 more
europepmc   +1 more source

The use of venetoclax in the treatment of acute lymphoblastic leukemia-a systematic review. [PDF]

Ther Adv Med Oncol
Kowalczyk A, Zarychta J, Zawitkowska J, Lejman M.   +3 more
europepmc   +1 more source

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

, 2007
信宏 兼村
openalex   +1 more source

Interferon Alfa Versus Interferon Alfa Plus Cytarabine Combination Therapy for Chronic Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials

, 2011
Rui Chen, Bin Ma, Kehu Yang, Jinhui Tian, Yali Liu, Li Zhao   +5 more
openalex   +1 more source

A rare case of variant acute promyelocytic leukemia with <i>FIP1L1-RARA</i> fusion gene: case report and literature review. [PDF]

Leuk Res Rep
Qiu Y, Zhou H, Wang S.
europepmc   +1 more source

DDX41-Mutated AML: A Case Report and Perspectives. [PDF]

JCO Precis Oncol
Yashar WM, Eide CA, Kurtz SE, Long N, Johnson KJ, Tognon CE, Druker BJ, Tyner JW, Swords R.   +8 more
europepmc   +1 more source

Acute painful lumbosacral paresthesia after intrathecal rituximab [PDF]

, 2011
E Jabbour, EL Bollen, G Antonini, G. W. van Imhoff, GD Shah, H Schulz, J. E. C. Bromberg, J. K. Doorduijn, J. W. Baars, JL Rubenstein, JL Rubenstein, K Ostermann, L Recht, M Pfreundschuh, M Pfreundschuh, M. J. van den Bent, R. Enting, RW Nelson, S Kim   +18 more
core   +4 more sources

Olive Leaf Extract (OLE) Anti-Tumor Activities Against Hematologic Tumors: Potential Therapeutic Implications for Pediatric Patients with B-Acute Lymphoblastic Leukemia. [PDF]

Nutrients
Airoldi I, Canè L, Brignole C, Ciampi E, Montagna D, Morandi F.   +5 more
europepmc   +1 more source

R-CHOP and R-cytarabine for transplant-ineligible MCL. [PDF]

Blood Adv
Klener P, Tušková L, Blahovcová P, Trněný M.   +3 more
europepmc   +1 more source

In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AML. [PDF]

Oncologist
Shen D, Yan W, Xia T, Shang L, Zhang J.
europepmc   +1 more source